Chronic myelogenous leukemia

From WikiMD.org
Jump to navigation Jump to search

Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia (pronounced: kroh-nik my-uh-loh-jus loo-kee-mee-uh), also known as CML or Chronic Myeloid Leukemia, is a type of cancer that starts in certain blood-forming cells of the bone marrow.

Etymology

The term "Chronic Myelogenous Leukemia" is derived from the Greek words "chronos" (time), "myelos" (marrow), "genous" (origin), and "leukemia" (white blood).

Definition

Chronic Myelogenous Leukemia is a slow-progressing and rare form of leukemia. It is characterized by the increased and unregulated growth of predominantly myeloid cells in the bone marrow and the accumulation of these cells in the blood.

Symptoms

Common symptoms of Chronic Myelogenous Leukemia include fatigue, weight loss, pain or fullness below the ribs on the left side, night sweats, and fever.

Diagnosis

Diagnosis of Chronic Myelogenous Leukemia typically involves blood tests, bone marrow tests, and genetic testing to look for the presence of the Philadelphia chromosome or the BCR-ABL1 gene.

Treatment

Treatment options for Chronic Myelogenous Leukemia include targeted therapy, chemotherapy, stem cell transplant, biologic therapy, and clinical trials.

Prognosis

The prognosis for Chronic Myelogenous Leukemia has greatly improved in recent years, thanks to advances in targeted therapies. However, the prognosis can vary depending on a number of factors, including the patient's age and overall health, the phase of the disease, and the patient's response to treatment.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski